Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
about
Silybin and the liver: from basic research to clinical practice.Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).Antioxidants as therapeutic agents for liver disease.Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials.High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy.
P2860
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Non-interferon-based therapy: ...... not afford interferon therapy.
@en
type
label
Non-interferon-based therapy: ...... not afford interferon therapy.
@en
prefLabel
Non-interferon-based therapy: ...... not afford interferon therapy.
@en
P2093
P2860
P1433
P1476
Non-interferon-based therapy: ...... not afford interferon therapy.
@en
P2093
Abdel-Rahman El-Zayadi
Adham El-Nakeeb
Ahmed El-Tawil
Ahmed Saied
Eman Barakat
Hanaa M Badran
Khaled Zalata
Mohy Attia
Osaima Selim
P2860
P304
P356
10.1111/J.1478-3231.2005.01110.X
P577
2005-08-01T00:00:00Z